Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes

BACKGROUND: Angiopoietin-like protein 4 (ANGPTL4) inhibits lipoprotein lipase and associates with dyslipidemia. The expression of ANGPTL4 is regulated by free fatty acids (FFA) that activate lipid-sensing peroxisome proliferator-activated receptors (PPARs), but FFA can also activate pattern recognit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Open Diabetes Res Care
Huvudupphovsmän: Tjeerdema, Nathanja, Georgiadi, Anastasia, Jonker, Jacqueline T, van Glabbeek, Marjolijn, Dehnavi, Reza Alizadeh, Tamsma, Jouke T, Smit, Johannes W A, Kersten, Sander, Rensen, Patrick C N
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2014
Ämnen:
Metabolism
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265148/
https://ncbi.nlm.nih.gov/pubmed/25512873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2014-000034
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk